• Abikoff H, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:802–811. [PubMed: 15213581]

  • Abikoff H, Hechtman L, Klein RG, et al. Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:820–829. [PubMed: 15213583]

  • Achenbach TM, Rescorla LA. Manual for the ASEBA School-age Forms and Profiles. Burlington: University of Vermont, Research Center for Children, Youth, and Families; 2001.

  • Achenbach TM, Dumenci L, Rescorla LA. DSM-oriented and empirically based approaches to constructing scales from the same item pools. Journal of Clinical Child and Adolescent Psychology. 2003;32:328–340. [PubMed: 12881022]

  • Adey P, Hewitt G, Hewitt J, et al. The Professional Development of Teachers: Practice and Theory. London: Kluwer; 2004.

  • Adler L, Dietrich A, Reimherr FW, et al. Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD. Annals of Clinical Psychiatry. 2006;18:107–113. [PubMed: 16754416]

  • Adler LA, Sutton VK, Moore RJ, et al. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. Journal of Clinical Psychopharmacology. 2006;26:648–652. [PubMed: 17110824]

  • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care. 2003;12:18–23. [PMC free article: PMC1743672] [PubMed: 12571340]

  • Alderson P, Sutcliffe K, Curtis K. Children’s consent to medical treatment. Hastings Centre Report. 2006;36:25–34. [PubMed: 17278870]

  • Alderson RM, Rapport MD, Kofler MJ. Attention-deficit/hyper-activity disorder and behavioral inhibition: a meta-analytic review of the stop-signal paradigm. Journal of Abnormal Child Psychology. 2007;35:745–758. [PubMed: 17668315]

  • Alexander R, Hargreaves L. Community Soundings: the Primary Review Regional Witness Sessions. Cambridge: University of Cambridge Faculty of Education; 2007.

  • Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005;65:1941–1949. [PubMed: 16380617]

  • Altshuler D, Daly M. Guilt beyond a reasonable doubt. Nature Genetics. 2007;39:813–815. [PubMed: 17597768]

  • Amador-Campos JA, Forns-Santacana M, Martorell-Balanzo B, et al. Confirmatory factor analysis of parents’ and teachers ratings of DSM-IV symptoms of attention deficit hyperactivity disorder in a Spanish sample. Psychological Reports. 2005;97:847–860. [PubMed: 16512303]

  • Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. Journal of Abnormal Psychology. 1987;15:75–90. [PubMed: 3553274]

  • American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:894–921. [PubMed: 17581453]

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Text Revision. 4th edn. Washington, DC: American Psychiatric Association; 2000. text revision.

  • Antrop I, Roeyers H, Van Oost P, et al. Stimulation seeking and hyperactivity in children with ADHD. The Journal of Child Psychology and Psychiatry. 2000;41:225–232. [PubMed: 10750548]

  • Antshel KM, Remer R. Social skills training in children with attention deficit hyperactivity disorder: a randomized-controlled clinical trial. Journal of Clinical Child and Adolescent Psychology. 2003;32:153–165. [PubMed: 12611031]

  • Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1211–1221. [PubMed: 9291722]

  • Armstrong F. Spaced Out: Policy, Difference and the Challenge of Inclusive Education. London: Kluwer; 2003.

  • Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine. Biological Psychiatry. 1989;25:222–228. [PubMed: 2539203]

  • Arnold LE, Elliot M, Sachs L, et al. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. Journal of Consulting and Clinical Psychology. 2003;71:713–727. [PubMed: 12924677]

  • Aubrey C, Godfrey R, Manigan S. Overcoming Barriers to Learning: How do we include young children with moderate learning difficulty?. Paper presented at the 12th Biennial Conference for Research on Learning and Instruction; Budapest. August 2007. 2007.

  • August GJ, Braswell L, Thuras P. Diagnostic stability of ADHD in a community sample of school-aged children screened for disruptive behavior. Journal of Abnormal Child Psychology. 1998;26:345–356. [PubMed: 9826293]

  • Avramidis A, Bayliss P, Burden R. A survey into mainstream teachers’ attitudes towards the inclusion of children with special educational needs in the ordinary school in one local education authority. Educational Psychology. 2000;20:191–211.

  • Bagwell CL, Molina BSG, Pelham WE, et al. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:1285–1292. [PubMed: 11699802]

  • Bailey S. ADHD - what’s in a name?. Paper presented at the British Education Research Association Conference; Warwick, England. 6– 9 September 2006; 2006. [accessed June 2008]. Available at: http://www​.leeds.ac.uk​/educol/documents/157738.htm.

  • Bambinski LM, Hartsough CS, Lambert NM. Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. The Journal of Child Psychology and Psychiatry. 1999;40:347–355. [PubMed: 10190336]

  • Barbaresi WJ, Olsen RD. An ADHD educational intervention for elementary schoolteachers: a pilot study. Journal of Developmental and Behavioral Pediatrics. 1998;19:94–100. [PubMed: 9584938]

  • Barbaresi WJ, Katusic SK, Colligan RC, et al. Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. Journal of Developmental and Behavioral Pediatrics. 2007;28:265–273. [PubMed: 17700078]

  • Barkley RA. Attention Deficit Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press; 1990.

  • Barkley RA. ADHD and the Nature of Self-Control. New York: Guilford; 1997.

  • Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. Journal of Safety Research. 2007;38:113–128. [PubMed: 17303170]

  • Barkley RA, Murphy KR. Attention-Deficit Hyperactivity Disorder: a Clinical Workbook. 2nd edn. New York: Guilford Press; 1998.

  • Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8 year old prospective follow up study. Journal of the American Academy of Child and Adolescent Psychiatry. 1990;29:546–557. [PubMed: 2387789]

  • Barkley RA, McMurray MB, Edelbrock CS, et al. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86:184–192. [PubMed: 2196520]

  • Barkley RA, Shelton TL, Crosswait C, et al. Multi-method psycho-educational intervention for preschool children with disruptive behavior: preliminary results at post-treatment. The Journal of Child Psychology and Psychiatry. 2000;41:319–332. [PubMed: 10784079]

  • Barkley RA, Fischer M, Smallish L, et al. Young adult follow-up of hyperactive children: antisocial activities and drug use. The Journal of Child Psychology and Psychiatry. 2004;45:195–211. [PubMed: 14982236]

  • Barkley RA, Fischer M, Smallish L, et al. Young adult outcomes of hyperactive children: adaptive functioning in major life activities. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:192–202. [PubMed: 16429090]

  • Barry TD, Lyman RD, Klinger LG. Academic underachievement and attention deficit/hyperactivity disorder: the negative impact of symptom severity on school performance. Journal of School Psychology. 2002;40:259–283.

  • Bauermeister JJ, Alegria M, Bird HR, et al. Are attention-hyperactivity deficits unidimensional or multidimensional syndromes? Empirical findings from a community survey. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31:423–431. [PubMed: 1592773]

  • Bauermeister J, Matos M, Reina G, et al. Comparison of the DSM-IV combined and inattentive types of ADHD in a school-based sample of Latino/ Hispanic children. The Journal of Child Psychology and Psychiatry. 2005;46:166–179. [PubMed: 15679525]

  • Bauman A. Stigmatization, social distance and exclusion because of mental illness: the individual with mental illness as a ‘stranger’ International Review of Psychiatry. 2007;19:131–135. [PubMed: 17464791]

  • Bekle B. Knowledge and attitudes about attention-deficit hyperactivity disorder (ADHD): a comparison between practicing teachers and undergraduate education students. Journal of Attention Disorders. 1994;7:151–161. [PubMed: 15260172]

  • Benjamin S, Nind M, Hall K, et al. Moments of inclusion and exclusion: pupils negotiating classroom contexts. British Journal of Sociology of Education. 2003;24:547–558.

  • Bereket A, Turan S, Karaman MG, et al. Height, weight, IGF-I, IGFBP–3 and thyroid functions in prepubertal children with attention deficit hyperacticity disorder: effect of methylphenidate treatment. Hormone Research. 2005;63:159–164. [PubMed: 15795512]

  • Berlin JA. Does blinding of readers affect the results of meta-analyses? The Lancet. 2001;350:185–186. [PubMed: 9250191]

  • Berwid OG, Curko Kera EA, Marks DJ, et al. Sustained attention and response inhibition in young children at risk for attention deficit/hyperactivity disorder. The Journal of Child Psychology and Psychiatry. 2005;46:1219–1229. [PubMed: 16238669]

  • Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Archives of General Psychiatry. 1992;49:728–738. [PubMed: 1514878]

  • Biederman J, Faraone SV, Doyle A, et al. Convergence of the child behavior checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity. The Journal of Child Psychology and Psychiatry. 1993;34:1241–1251. [PubMed: 8245144]

  • Biederman J, Milberger S, Faraone SV, et al. Family-environment risk factors for attention-deficit hyperactivity disorder: a test of Rutter’s indicators of adversity. Archives of General Psychiatry. 1995;52:464–470. [PubMed: 7771916]

  • Biederman J, Faraone S, Milberger S, et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Archives of General Psychiatry. 1996;53:437–446. [PubMed: 8624187]

  • Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005;116:e777–e784. [PubMed: 16322134]

  • Biederman J, Mick E, Surman C, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry. 2006;59:829–835. [PubMed: 16373066]

  • Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry. 2006;163:1730–1738. [PubMed: 17012683]

  • Biederman J, Monuteaux MC, Spencer T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. American Journal of Psychiatry. 2008;165:597–603. [PubMed: 18316421]

  • Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Current Medical Research and Opinion. 2005;21:195–206. [PubMed: 15801990]

  • Blachman DR, Hinshaw SP. Patterns of friendship among girls with and without attention-deficit/hyperactivity disorder. Journal of Abnormal Child Psychology. 2002;30:625–640. [PubMed: 12481976]

  • Bloomquist ML, August GJ, Ostrander R. Effects of a school-based cognitive-behavioral intervention for ADHD children. Journal of Abnormal Child Psychology. 1991;19:591–605. [PubMed: 1770187]

  • Bluebond-Langner M, DeCicco A, Belasco J. Involving children with life-shortening illnesses in decisions about participation in clinical research: a proposal for shuttle diplomacy and negotiation, Ethics and Research with Children. Kodish E, editor. Oxford; Oxford University Press; 2005. pp. 323–344.

  • Bohnstedt BN, Kronenberger WG, Dunn DW, et al. Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine: a comparison of parents and teachers as informants. Journal of Attention Disorders. 2005;8:153–159. [PubMed: 16110045]

  • Boonstra AM, Oosterlaan J, Sergent JA, et al. Executive functioning in adult ADHD: a meta-analytic review. Psychological Medicine. 2005;35:1097–1108. [PubMed: 16116936]

  • Bor W, Sanders MR, Markie-Dadds C. The effects of the Triple P-Positive Parenting Program on preschool children with co-occurring disruptive behavior and attentional/hyperactive difficulties. Journal of Abnormal Child Psychology. 2002;30:571–587. [PubMed: 12481972]

  • Botting N, Powls A, Cooke RWI, et al. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birth weight children at 12 years. The Journal of Child Psychology and Psychiatry. 1997;38:931–941. [PubMed: 9413793]

  • Boyle MH, Offord DR, Racine YA, et al. Adequacy of interviews vs. checklists for classifying childhood psychiatric disorder based on parent reports. Archives of General Psychiatry. 1997;54:793–799. [PubMed: 9294369]

  • Bradley C. The behavior of children receiving benzedrine. American Journal of Psychiatry. 1937;94:577–585.

  • Bramham J, Young S, Bickerdike A, et al. Evaluation of group cognitive behavioural therapy for adults with ADHD. Journal of Attention Disorders. 2008 Epub 1087054708314596v1. [PubMed: 18310557]

  • Brazier J, Roberts J. The estimation of a preference-based measure of health from the SF-12. Medical Care. 2004;42:851–859. [PubMed: 15319610]

  • Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF–36 Health Survey. Journal of Clinical Epidemiology. 1998;51:1115–1128. [PubMed: 9817129]

  • British Medical Association & the Royal Pharmaceutical Society of Great Britain . British National Formulary (BNF). Vol. 54. London: British Medical Association & Royal Pharmaceutical Society of Great Britain; 2007.

  • British Medical Association, the Royal Pharmaceutical Society of Great Britain & the Royal College of Paediatrics and Child Health, et al. BNF for Children. London: BMJ Pub Group; 2005.

  • Brookes K-J, Mill J, Guindalini C, et al. A common haplotype of the dopamine transporter gene associated with attention deficit hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Archives of General Psychiatry. 2006;63:74–81. [PubMed: 16389200]

  • Brown GL, Hunt RD, Ebert MH, et al. Plasma levels of d-amphetamine in hyperactive children. Psychopharmacology. 1979;62:133–140. [PubMed: 111276]

  • Brown RT, Wynne ME, Slimmer LW. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. Journal of Clinical Psychiatry. 1984;45:473–476. [PubMed: 6386794]

  • Brown RT, Wynne ME, Medenis R. Methylphenidate and cognitive therapy: a comparison of treatment approaches with hyperactive boys. Journal of Abnormal Child Psychology. 1985;13:69–87. [PubMed: 3973253]

  • Brown RT, Perwein A, Faries DE, et al. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clinical Pediatrics. 2006;45:819–827. [PubMed: 17041169]

  • Brown TE. Brown Attention-Deficit Disorder Scales. San Antonio, Texas: The Psychological Corporation, Harcourt Brace; 1996.

  • Brown TE. Brown Attention-Deficit Disorder Scales for Children. San Antonio, Texas: The Psychological Corporation, Harcourt Brace; 2001.

  • Buhrmester D, Whalen CK, Henker B, et al. Prosocial behaviour in hyperactive boys: effects of stimulant medication in comparison with normal boys. Journal of Abnormal Child Psychology. 1992;20:103–121. [PubMed: 1548391]

  • Bukstein O. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder. Adolescent Medicine: State of the Art Reviews. 2006;19:242–253. [PubMed: 18822830]

  • Burd L, Klug MG, Coumbe MJ, et al. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care. Journal of Child Neurology. 2003;18:555–561. [PubMed: 13677583]

  • Burd L, Klug MG, Coumbe MJ, et al. The attention-deficit hyperactivity disorder paradox: 2. Phenotypic variability in prevalence and cost of comorbidity. Journal of Child Neurology. 2003;18:653–660. [PubMed: 14572145]

  • Burgess I. Service innovations: attention-deficit hyperactivity disorder: development of a multi-professional integrated care pathway. Psychiatric Bulletin. 2002;26:148–151.

  • Bussing R, Gary FA, Leon CE, et al. General classroom teachers’ information and perceptions of attention deficit hyperactivity disorder. Behavioral Disorders. 2002;27:327–339.

  • Butter HJ, Lapierre Y, Firestone P, et al. A comparative study of the efficacy of ACTH4–9 analogue, methylphenidate, and placebo on attention deficit disorder with hyperkinesis. Journal of Clinical Psychopharmacology. 1983;3:226–230. [PubMed: 6309918]

  • Camp B, Bash MA. Think Aloud: Increasing Social and Cognitive Skills - A Problem-Solving Program for Children: Primary Level. Champaign, Illinois: Research Press; 1981.

  • Canino G, Shrout PE, Rubio-Stipec M, et al. The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment. Archives of General Psychiatry. 2004;61:85–93. [PubMed: 14706947]

  • Carter CM, Urbanowitz M, Hemsley R, et al. Effects of a food diet in attention deficit disorder. Archives of Disease in Childhood. 1993;69:564–568. [PMC free article: PMC1029619] [PubMed: 8257176]

  • Caruana A, Vassallo R. Children’s perception of their influence over purchases: the role of parental communication patterns. Journal of Consumer Marketing. 2003;20:55–66.

  • Casat CD, Pleasants DZ, Fleet JVW. A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacology Bulletin. 1987;23:120–121. [PubMed: 3110853]

  • Castellanos FX, Giedd JN, Elia J, et al. Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:589–596. [PubMed: 9136492]

  • Cephalon UK Limited . Provigil 100 mg Tablets, Provigil 200 mg Tablets. Summary of Product Characteristics. 2008. Available at: http://emc​.medicines.org.uk.

  • Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Archives of Pediatrics and Adolescent Medicine. 2002;156:504–511. [PubMed: 11980558]

  • Chen WJ, Faraone SV, Biederman J, et al. Diagnostic accuracy of the child behavior checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis. Journal of Consulting and Clinical Psychology. 1994;62:1017–1025. [PubMed: 7806710]

  • Cochrane Collaboration. Review Manager (RevMan) [computer program] Version 425 for Windows. Oxford: The Cochrane Collaboration; 2005.

  • Coghill D, Spende Q, Barton J, et al. Measuring Quality of Life in Children with Attention-Deficit-Hyperactivity Disorder in the UK. Poster presented at 16th World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP); 22–26 August 2004; Berlin, Germany. 2004.

  • Coghill D, Spiel G, Baldursson G, et al. Which factors impact on clinician-rated impairment in children with ADHD? European Child and Adolescent Psychiatry. 2006;13(Suppl 1):117–129. [PubMed: 17177013]

  • Compas BE, Benson M, Boyer M, et al. Problem-solving and problem-solving therapies, Child and Adolescent Psychiatry. 4th edn. Rutter M, Taylor E, editors. Oxford: Blackwell; 2002. pp. 938–948.

  • Conners CK. A teacher rating scale for use in drug studies with children. American Journal of Psychiatry. 1969;126:884–888. [PubMed: 4900822]

  • Conners CK. Food Additives and Hyperactive Children. New York: Plenum; 1980.

  • Conners CK. Conners Rating Scales-Revised (CRS-R). North Tonawanda, New York: Multi-Health Systems; 1997.

  • Conners CK, Taylor E. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Archives of General Psychiatry. 1980;37:922–930. [PubMed: 7406656]

  • Conners CK, Goyette CH, Southwick DA, et al. Food additives and hyperkinesis: a controlled double-blind experiment. Pediatrics. 1976;58:154–66. [PubMed: 781610]

  • Conners CK, Casat CD, Gualtieri CT, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;34:1314–1321. [PubMed: 8885585]

  • Conners CK, Wells KC, Parker JDA, et al. A new self-report scale for assessment of adolescent psychopathology: factor structure, reliability, validity, and diagnostic sensitivity. Journal of Abnormal Child Psychology. 1997;25:487–497. [PubMed: 9468109]

  • Conners CK, Sitarenios G, Parker JDA, et al. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability and criterion validity. Journal of Abnormal Child Psychology. 1998;26:279–291. [PubMed: 9700520]

  • Cooper P, Ideus K. Attention Deficit/Hyperactivity Disorder: A Practical Guide for Teachers. London: David Fulton; 1996.

  • Corkum PV, McKinnon MM, Mullane JC. The effect of involving classroom teachers in a parent training program for families of children with ADHD. Child and Family Behavior Therapy. 2005;27:29–49.

  • Costello AJ, Edelbrock CS, Kalas R, et al. NIMH Diagnostic Interview Schedule for Children. Bethesda, Maryland: NIMH; 1982.

  • Couture C, Royer E, Dupuis FA, et al. Comparison of Quebec and British teachers’ beliefs about, training in and experience with attention deficit hyperactivity disorder. Emotional Behavioural Difficulties. 2003;8:284–302.

  • Cuffe SP, Moore CG, McKeown RE. Prevalence and correlates of ADHD symptoms in the national health interview survey. Journal of Attention Disorders. 2005;9:392–401. [PubMed: 16371662]

  • Cunningham C, Boyle M. Preschoolers at risk for attention-deficit hyperactivity disorder and oppositional defiant disorder: family, parenting, and behavioural correlates. Journal of Abnormal Child Psychology. 2002;30:555–569. [PubMed: 12481971]

  • Curtis DF, Pisecco S, Hamilton RJ, et al. Teacher perceptions of classroom interventions for children with ADHD: a cross-cultural comparison of teachers in the United States and New Zealand. School Psychology Quarterly. 2006;21:171–196.

  • Curtis L, Netten A. Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit; 2006. Available from: http://www​.pssru.ac.uk/

  • Dahl R, Pelham W, Wierson M. The role of sleep disturbances in attention deficit disorder symptoms: a case study. Journal of Pediatric Psychology. 1991;16:229–239. [PubMed: 2061790]

  • Dall’Alba G, Sandberg J. Unveiling professional development: a critical review of stage models. Review of Education Research. 2006;76:383–412.

  • Dalsgaard S, Mortensen PB, Frydenberg M, et al. Conduct problems, gender and the adult psychiatric outcome of children with attention-deficit hyperactive disorder. British Journal of Psychiatry. 2002;181:416–421. [PubMed: 12411268]

  • Deatrick JA, Faux SA. Conducting qualitative studies with children and adolescents, Qualitative Nursing Research: a Contemporary Dialogue. Morse JM, editor. Newbury Park, California: Sage; 1991. pp. 185–203.

  • DeBar LL, Lynch FL, Boles M. Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities. Journal of Behavioral Health Services and Research. 2004;31:312–323. [PubMed: 15263869]

  • De Civita M, Regier D, Alamgir AH, et al. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics. 2005;23:659–685. [PubMed: 15987225]

  • Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine. 2002;21:1575–1600. [PubMed: 12111921]

  • Department of Health . National Service Framework for Children, Young People and Maternity Services The Mental Health and Psychological Well-being of Children and Young People. London: HMSO; 2004.

  • De Ridder A, De Graeve A. Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium. Clinical Drug Investigation. 2006;26:75–90. [PubMed: 17163238]

  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7:177–188. [PubMed: 3802833]

  • DfES . Special Educational Needs Code of Practice. Reference dfes/581/ 2001. 2001. [accessed April 2007]. Available at: http://publications​.teachernet​.gov.uk/eOrderingDownload​/DfES​%200581%20200MIG2228.pdf.

  • Dickstein SG, Bannon K, Castellanos FX, et al. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. The Journal of Child Psychology and Psychiatry. 2006;47:1051–1062. [PubMed: 17073984]

  • Dolan P. Modelling valuations for EuroQol health states. Medical Care. 1997;35:1095–1108. [PubMed: 9366889]

  • Donnelly M, Haby MM, Carter R, et al. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry. 2004;38:592–601. [PubMed: 15298581]

  • Döpfner M, Breuter D, Schürmann S, et al. Effectiveness of an adaptive multimodal treatment in children with attention-deficit hyperactivity disorder: global outcome. European Child and Adolescent Psychiatry. 2004;13(Suppl 1):i117–i129. [PubMed: 15322962]

  • Dreger RM, Lewis PM, Rich TA, et al. Behavioral classification project. Journal of Consulting Psychology. 1964;28:1–13. [PubMed: 14121173]
    Journal of the American Academy of Child and Adolescent Psychiatry. 31:210–218.

  • Dretzke J, Frew E, Davenport C, et al. The Effectiveness and Cost-Effectiveness of Parent Training/Education Programmes for the Treatment of Conduct Disorder, Including Oppositional Defiant Disorder, in Children, Health Technology Assessment, 9. Tunbridge Wells: Gray Publishing; 2005. [PubMed: 16336845]

  • Dreyfus HL, Dreyfus SE. A Phenomenology of Skill Acquisition as a Basis For A Merleau-Pontian Non-Representationalist Cognitive Science. University of California, Berkley, Department of Philosophy; 1986. Unpublished manuscript.

  • Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the British Medical Journal. British Medical Journal. 1996;313:275–283. [PMC free article: PMC2351717] [PubMed: 8704542]

  • Dulcan M, Popper CW. Concise Guide to Child and Adolescent Psychiatry. Washington: American Psychiatric Press; 1991.

  • DuPaul GJ, Eckert TL. The effects of school-based interventions for attention deficit hyperactivity disorder: a meta analysis. School Psychology Review. 1997;26:5–27.

  • DuPaul GJ, Reid R, Power TJ, et al. ADHD Rating Scale-IV. New York: Guilford Press; 1998.

  • DuPaul GJ, McGoey KE, Eckert TL, et al. Preschool children with attention deficit / hyperactivity disorder: impairments in behavioral, social, and school functioning. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:508–515. [PubMed: 11349694]

  • Eaves LJ, Silberg JL, Meyer JM, et al. Genetics and developmental psychopathology: 2. The main effects of genes and environment on behavioral problems in the Virginia twin study of adolescent behavioral development. The Journal of Child Psychology and Psychiatry. 1997;38:965–980. [PubMed: 9413795]

  • Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: methods of developing guidelines for efficient drug use in primary care. British Medical Journal. 1998;316:1232–1235. [PMC free article: PMC1112989] [PubMed: 9553004]

  • Edelbrock C. Behavioral ratings of children diagnosed for attention deficit disorder. Psychiatric Annals. 1986;16:36–40.

  • Edelbrock C, Costello AJ, Dulcan MK, et al. Parent-child agreement on child psychiatric symptoms assessed via structured interview. The Journal of Child Psychology and Psychiatry. 1986;27:181–190. [PubMed: 3958075]

  • Efron D, Jarman FC, Barker MJ. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. Journal of Paediatrics and Child Health. 1998;34:288–292. [PubMed: 9633980]

  • Egger J, Carter CM, Graham PJ, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. The Lancet. 1985;1:540–545. [PubMed: 2857900]

  • Eli Lilly and Company Ltd . Strattera 10 mg, 18 mg, 25 mg, 40 mg, 60 mg or 80 mg Hard Capsules. Summary of Product Characteristics. 2008. Available at: http://emc​.medicines.org.uk.

  • Epstein JN, Johnson D, Conners CK. CAADID: Conners Adult ADHD Diagnostic Interview for DSM-IV Technical Manual. North Towanda, NY: Multihealth Systems; 2001.

  • Epstein JN, Willoughby M, Valencia EY, et al. The role of children’s ethnicity in the relationship between teacher ratings of attention-deficit/hyperactivity disorder and observed classroom behavior. Journal of Consulting and Clinical Psychology. 2005;73:424–434. [PubMed: 15982140]

  • Ernhardt D, Hinshaw SP. Initial sociometric impressions of attention-deficit hyperactivity disorder and comparison boys: predictions from social behaviors and from nonbehavioral variables. Journal of Consulting and Clinical Psychology. 1994;62:833–842. [PubMed: 7962888]

  • Eysenck NT, Rachman ST. The application of learning theory to child psychiatry, Modern Perspectives in Child Psychiatry. Howells TC, editor. NewYork: Brunner/Mazel; 1971. pp. 104–169.

  • Famularo R, Kinscherff R, Fenton T. Psychiatric diagnoses of maltreated children: preliminary findings. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31:863–867. [PubMed: 1400118]

  • Faraone SV. The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. European Child and Adolescent Psychiatry. 2005;14:1–10. [PubMed: 15756510]

  • Faraone SV, Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. Journal of Attention Disorders. 2005;9:384–391. [PubMed: 16371661]

  • Faraone S, Biederman J, Monuteaux MC. Further evidence for the diagnostic continuity between child and adolescent ADHD. Journal of Attention Disorders. 2002;6:5–13. [PubMed: 12045756]

  • Faraone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2:104–113. [PMC free article: PMC1525089] [PubMed: 16946911]

  • Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry. 2005;57:1313–1323. [PubMed: 15950004]

  • Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine. 2006;36:159–165. [PubMed: 16420712]

  • Farrington DP. Delinquency Prevention in the First Few Years of Life. Plenary Address from 4th European Conference on Law and Psychology; Barcelona, Spain. 1994.

  • Farrington DP. The Twelfth Jack Tizard Memorial Lecture. The development of offending and antisocial behaviour from childhood: key findings from the Cambridge Study in Delinquent Development. The Journal of Child Psychology and Psychiatry. 1995;36:929–964. [PubMed: 7593403]

  • FDA . Review of AERS data for marketed safety experience during stimulant therapy: death, sudden death, cardiovascular SAEs (including stroke). Meeting report. 2004.

  • FDA . FDA asks attention-deficit hyperactivity disorder (ADHD) drug manufacturers to develop patient medication guides. 2008. [accessed January 2008]. http://www​.fda.gov/cder​/drug/infopage/ADHD/default.htm.

  • FDA . FDA alert for healthcare professionals: Adderall and Adderall XR (amphetamine). 2008. [accessed January 2008]. http://www​.fda.gov/cder​/drug/InfoSheets/HCP​/AdderallHCPSheet.pdf.

  • Fehlings DL, Roberts W, Humphries T, et al. Attention deficit hyperactivity disorder: does cognitive behavioral therapy improve home behavior? Journal of Developmental and Behavioral Pediatrics. 1991;12:223–228. [PubMed: 1939676]

  • Feighner JP, Robins E, Guze EB, et al. Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry. 1972;26:57–63. [PubMed: 5009428]

  • Feldman H, Cumrine P, Handen BL, et al. Methylphenidate in children with seizures and attention-deficit disorder. American Journal of Diseases in Children. 1989;143:1081–1086. [PubMed: 2672786]

  • Fennell D, Liberato A. Learning to live with OCD: labelling, the self, and stigma. Deviant Behavior. 2007;28:305–331.

  • Ferguson DM, Horwood LJ, Lloyd M. Confirmatory factor models of attention deficit and conduct disorder. The Journal of Child Psychology and Psychiatry. 1991;32:257–274. [PubMed: 2033107]

  • Findling RL, Short EJ, Manos MJ. Short-term cardiovascular effects of methylphenidate and Adderall. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:525–529. [PubMed: 11349696]

  • Findling RL, Quinn D, Hatch SJ, et al. Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with attention-deficit/hyperactivity disorder. European Child and Adolescent Psychiatry. 2006;15:450–459. [PubMed: 16791541]

  • Firestone P, Kelly MJ, Goodman JT, et al. Differential effects of parent training and stimulant medication with hyperactives: a progress report. American Academy of Child Psychiatry. 1981;20:135–147. [PubMed: 7217546]

  • Firestone P, Crowe D, Goodman JT, et al. Vicissitudes of follow-up studies: differential effects of parent training and stimulant medication with hyperactives. American Journal of Orthopsychiatry. 1986;56:184–194. [PubMed: 3706498]

  • Fischer M, Barkley RA, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. Journal of Consulting and Clinical Psychology. 1990;58:580–588. [PubMed: 2254504]

  • Fischer M, Barkley RA, Smallish L, et al. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes. Accident Analysis and Prevention. 2007;39:94–105. [PubMed: 16919226]

  • Fletcher KE, Fischer M, Barkley RA, et al. A sequential analysis of the mother-adolescent interactions of ADHD, ADHD / ODD, and normal teenagers during neutral and conflict discussions. Journal of Abnormal Child Psychology. 1996;24:271–297. [PubMed: 8836802]

  • Flynn Pharma Ltd . Medikinet Tablets. Summary of Product Characteristics. 2007. Available at: http://emc​.medicines.org.uk.

  • Flynn Pharma Ltd . Medikinet XL. Summary of Product Characteristics. 2007. Available at: http://emc​.medicines.org.uk.

  • Fonagy P, Target M, Cottrell D, et al. What Works for Whom? A Critical Review of Treatments for Children and Adolescents. New York: Guilford Press; 2002.

  • Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:1203–1211. [PubMed: 14560170]

  • Ford T, Goodman R, Meltzer H. The relative importance of child, family, school and neighbourhood correlates of childhood psychiatric disorder. Social Psychiatry and Psychiatric Epidemiology. 2004;39:487–496. [PubMed: 15205734]

  • Foster EM, Jensen PS, Schlander M, et al. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Services Research. 2007;42:165–82. [PMC free article: PMC1955245] [PubMed: 17355587]

  • Fowler M. the National Education Committee . CH.A.D.D. Educator’s Manual: an In-Depth Look at Attention Deficit Disorders from an Educational Perspective. Plantation, Florida: CH.A.D.D; 1992.

  • Frazier TW, Youngstrom EA, Glutting JJ, et al. ADHD and achievement: meta analysis of the child, adolescent, and adult literatures and a concomitant study with college students. Journal of Learning Disabilities. 2007;40:49–65. [PubMed: 17274547]

  • Frick PJ, Lahey BB, Kamphaus RW, et al. Academic underachievement and the disruptive behavior disorders. Journal of Consulting and Clinical Psychology. 1991;59:289–294. [PubMed: 2030190]

  • Frouke EPL, Ferdinand RF, Oldehinkel AJ. Classes of adolescents with disruptive behaviors in a general population sample. Social Psychiatry and Psychiatric Epidemiology. 2005;40:931–938. [PubMed: 16222441]

  • Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology. 2006;59:7–10. [PubMed: 16360555]

  • Gadow KD, Sverd J, Sprafkin J, et al. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Archives of General Psychiatry. 1999;56:337–338. [PubMed: 10197827]

  • Galloway D, Leo EL, Rogers C, et al. Motivational styles in English and mathematics among children identified as having special educational needs. British Journal of Educational Psychology. 1995;65:477–487. [PubMed: 8580048]

  • Gaub M, Carlson CL. Behavioural characteristics of DSM-IV ADHD subtypes in a school-based population. Journal of Abnormal Child Psychology. 1997;25:103–111. [PubMed: 9109027]

  • Gerring JP, Brady KD, Chen A, et al. Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:647–654. [PubMed: 9628085]

  • Gilger JW, Pennington BF, DeFries JC. A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31:343–348. [PubMed: 1564037]

  • Gilmore A, Milne R. Methylphenidate in children with hyperactivity: review and cost analysis. Pharmacoepidemiology and Drug Safety. 2001;10:85–94. [PubMed: 11499858]

  • Gittelman-Klein R, Klein DF, Abikoff H, et al. Relative efficacy of methylphenidate and behavior modification in hyperkinetic children: an interim report. Journal of Abnormal Child Psychology. 1976;4:361–379. [PubMed: 1002948]

  • Gittelman-Klein R, Klein DF, Katz S, et al. Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results. Archives of General Psychiatry. 1976;33:1217–1231. [PubMed: 971031]

  • Gittelman-Klein R, Landa B, Mattes JA, et al. Methylphenidate and growth in hyperactive children. Archives of General Psychiatry. 1988;45:1127–1130. [PubMed: 3058088]

  • Gjone H, Stevenson J, Sundet JM. Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:588–596. [PubMed: 8935205]

  • GlaxoSmithKline UK. Zyban 150 mg Prolonged Release Film-Coated Tablets. Summary of Product Characteristics. 2008. Available at: http://emc​.medicines.org.uk.

  • Glutting JJ, Youngstrom EA, Watkins MW. ADHD and college students: exploratory and confirmatory factor structures with student and parent data. Psychological Assessment. 2005;17:44–55. [PubMed: 15769227]

  • Goffman E. Asylums: Essays on the Social Situation of Mental Patients and Other Inmates. Harmondsworth: Penguin; 1968.

  • Goffman E. Stigma: Notes on the Management of Spoiled Identity. Harmondsworth: Penguin; 1968.

  • Gomez R, Harvey J, Quick C, et al. DSM-IV AD/HD: confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children. The Journal of Child Psychology and Psychiatry. 1999;40:265–274. [PubMed: 10188709]

  • Gonzalez LO, Sellers EW. The effects of a stress-management program on self-concept, locus of control, and the acquisition of coping skills in school-age children diagnosed with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychiatric Nursing. 2002;15:5–15. [PubMed: 11939420]

  • Goodman R. Psychometric properties of the Strengths and Difficulties Questionnaire. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:1337–1345. [PubMed: 11699809]

  • Gowers S, Thomas S, Deeley S. Can primary schools contribute effectively to Tier I Child Mental Health Services? Clinical Child Psychology and Psychiatry. 2004;9:419–425.

  • GRADE Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal. 2004;328:1490–1497.

  • Gray J, Sime N. A report for the committee of inquiry into discipline in schools. Part 1: Findings from the national survey of teachers in England and Wales, The Elton Report 1989 Enquiry into Discipline in Schools. London: HMSO; 1988.

  • Green H, McGinnity A, Meltzer H, et al. Mental Health of Children and Young People in Great Britain, 2004, A survey carried out by the Office for National Statistics on behalf of the Department of Health and the Scottish Executive. Basingstoke: Palgrave Macmillan; 2005.

  • Green VA, O’Reilly M, Itchon J, et al. Persistence of early emerging aberrant behavior in children with developmental disabilities. Research in Developmental Disabilities. 2004;26:47–55. [PubMed: 15590237]

  • Greenberg LM, Deem MA, McMahon S. Effects of dextro-amphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children. American Journal of Psychiatry. 1972;129:44–51. [PubMed: 4562464]

  • Greenhill LL, Findling RL, Swanson JM, et al. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;109:E39. [PubMed: 11875167]

  • Greenhill LL, Muniz R, Ball RR, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:817–823. [PubMed: 16832318]

  • Gross-Tsur V, Manor O, van der Meere J, et al. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? Journal of Pediatrics. 1997;130:40–44. [PubMed: 9003849]

  • Gudex C, Dolan P, Kind P, et al. Health state valuations from the general public using the Visual Analogue Scale. Quality of Life Research. 1996;5:521–531. [PubMed: 8993098]

  • Guevara JP, Mandell DS. Costs associated with attention deficit hyperactivity disorder: overview and future projections. Expert Review on Pharmacoeconomics and Outcomes Research. 2003;3:201–210. [PubMed: 19807367]

  • Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:71–78. [PubMed: 11433056]

  • Hagerman RJ. Psychopharmacological interventions in fragile x syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Mental Retardation and Developmental Disabilities Research Reviews. 1999;5:305–313.

  • Hakkaart-van Roijen L, Zwirs BWC, Bouwmans C, et al. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). European Child and Adolescent Psychiatry. 2007;16:316–326. [PubMed: 17483870]

  • Hankin CS. ADHD and its impact on the family. Drug Benefit Trends. 2001;13(Suppl C):15–16.

  • Hankin CS, Wright A, Gephart H. The burden of attention deficit/ hyperactivity disorder. Drug Benefit Trends. 2001;13:7–14.

  • Harley JP, Ray RS, Tomasi L, et al. Hyperkinesis and food additives: testing the Feingold hypothesis. Pediatrics. 1978;61:818–827. [PubMed: 353681]

  • Hartl T, Duffany S, Allen G, et al. Relationships among compulsive hoarding, trauma, and attention-deficit/hyperactivity disorder. Behaviour Research and Therapy. 2005;43:269–276. [PubMed: 15629755]

  • Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:886–894. [PubMed: 12874489]

  • Hechtman L, Weiss G. Long-term outcome of hyperactive children. American Journal of Orthopsychiatry. 1983;53:532–541. [PubMed: 6349374]

  • Heinrich H, Gevensleben H, Strehl U. Annotation: Neurofeedback – train your brain to train behaviour. The Journal of Child Psychology and Psychiatry. 2006;48:3–16. [PubMed: 17244266]

  • Hemmer SA, Pasternak JF, Zecker SG, et al. Stimulant therapy and seizure risk in children with ADHD. Pediatric Neurology. 2001;24:99–102. [PubMed: 11275457]

  • Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit /hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18:485–503. [PubMed: 15291727]

  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21:1539–1558. [PubMed: 12111919]

  • Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. American Journal of Psychiatry. 1996;153:1143–1146. [PubMed: 8780416]

  • Hinnenthal JA, Perwien AR, Sterling KL. A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatric Services. 2005;56:1593–1599. [PubMed: 16339625]

  • Hinshaw SP. Preadolescent girls with attention-deficit/hyperactivity disorder: I. Background characteristics, comorbidity, cognitive and social functioning, and parenting practices. Journal of Consulting and Clinical Psychology. 2002;70:1086–1098. [PubMed: 12362959]

  • Hinshaw SP. The stigmatization of mental illness in children and parents: developmental issues, family concerns, and research needs. The Journal of Child Psychology and Psychiatry. 2005;46:714–734. [PubMed: 15972067]

  • Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder: a placebo-controlled double-blind study. European Journal of Clinical Nutrition. 2004;58:467–473. [PubMed: 14985685]

  • HMSO. The Elton Report Enquiry into Discipline in Schools. London: HMSO; 1989.

  • Ho TP, Leung PWL, Luk ESL, et al. Establishing the constructs of childhood behavioral disturbance in a Chinese population: a questionnaire study. Journal of Abnormal Child Psychology. 1996;24:417–431. [PubMed: 8886939]

  • Hoath FE, Sanders MR. A feasibility study of enhanced group Triple P—Positive Parenting Program for parents of children with attention-deficit/hyperactivity disorder. Behaviour Change. 2002;19:191–206.

  • Hoofdakker BJ, van den Veen-Mulders L, van der Sytema S, et al. Effectiveness of behavioural parent training for children with ADHD in routine clinical practice: a randomized controlled study. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:1263–1271. [PubMed: 17885567]

  • Horwitz AV, Videon TM, Schmitz MF, et al. Rethinking twins and environments: possible social sources for assumed genetic influences in twin research. Journal of Health and Social Behavior. 2003;44:111–129. [PubMed: 12866384]

  • House of Commons Education and Skills Committee . Special Educational Needs: Third Report of Session 2005–06. 2006. Available at: http://www​.publications​.parliament.uk/pa​/cm200506/cmselect/cmeduski/478/478i.pdf.

  • Hudziak J, Heath AC, Madden PF, et al. Latent class and factor analysis of DSM-IV ADHD: a twin study of female adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:848–857. [PubMed: 9695447]

  • Hughes L, Cooper P. Understanding and Supporting Children with ADHD: Strategies for Teachers, Parents and other Professionals. London: Paul Chapman; 2006.

  • Ialongo NS, Lopez M, Horn WF, et al. Effects of psychostimulant medication on self-perceptions of competence, control, and mood in children with attention deficit hyperactivity disorder. Journal of Clinical Child Psychology. 1994;23:161–173.

  • Information Centre, The. Prescription Cost Analysis England 2006. The Information Centre, Prescribing Support Unit, NHS; 2006. Available at: http://www​.ic.nhs.uk​/webfiles/publications/pca2006/PCA_2006​.pdf.

  • Jacobs BW. Individual and group therapy, Child and Adolescent Psychiatry. 4th edn. Rutter M, Taylor E, editors. Oxford: Blackwell; 2002. pp. 983–997.

  • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Controlled Clinical Trials. 1996;17:1–12. [PubMed: 8721797]

  • Jaffee SR, Price TS. Gene-environment correlations: a review of the evidence and implications for prevention of mental illness. Molecular Psychiatry. 2007;12:432–442. [PMC free article: PMC3703541] [PubMed: 17453060]

  • Janssen-Cilag Ltd . Concerta XL 18 mg Prolonged-Release Tablets, Concerta XL 36 mg Prolonged-Release Tablets. Summary of Product Characteristics. 2008. Available at: http://emc​.medicines.org.uk.

  • Janssen-Cilag Ltd . Concerta XL 27 mg Prolonged-Release Tablets. Summary of Product Characteristics. 2008. Available at: http://emc​.medicines.org.uk.

  • Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1065–1079. [PubMed: 9256586]

  • Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;46:989–1002. [PubMed: 17667478]

  • Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:147–158. [PubMed: 11211363]

  • Jensen PS, Garcia JA, Glied S, et al. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. American Journal of Psychiatry. 2005;162:1628–1636. [PubMed: 16135621]

  • Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:989–1002. [PubMed: 17667478]

  • Jerome L, Habinski L, Segal A. Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique. Current Psychiatry Reports. 2006;8:416–426. [PubMed: 16968625]

  • Johnston C, Mash EJ. Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clinical Child and Family Psychology Review. 2001;4:183–207. [PubMed: 11783738]

  • Joint Formulary Committee. British National Formulary 55. London: Pharmaceutical Press; 2008.

  • Joint Royal College of Paediatrics and Child Health/Neonatal and Paediatric Pharmacists Group Standing Committee on Medicines. The Use of Unlicensed Medicines or Licensed Medicines for Unlicensed Applications in Paediatric Practice: Policy Statement. London: Royal College of Paediatrics and Child Health; 2000.

  • Joyce B, Showers B. Improving inservice training: the messages of research. Educational Leadership. 1980;37:379–385.

  • Kapalka GM. Avoiding repetitions reduces ADHD children’s management problems in the classroom. Emotional and Behavioural Difficulties. 2005;10:269–279.

  • Kaplan BJ, McNicol J, Conte RA, et al. Dietary replacement in preschool-aged hyperactive boys. Pediatrics. 1989;83:7–17. [PubMed: 2909977]

  • Keith R. Auditory Continuous Performance Test. San Antonio, Texas: Psychological Corporation; 1994.

  • Kelleher KJ, McInerny TK, Gardner WP, et al. Increasing identification of psychosocial problems: 1979–1996. Pediatrics. 2000;105:1313–1321. [PubMed: 10835074]

  • Kelleher KJ, Childs GE, Harman JS. Healthcare costs for children with attention-deficit/hyperactivity disorder. TEN: The Economics of Neuroscience. 2001;3:60–63.

  • Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004;114:e1–e8. [PubMed: 15231966]

  • Kendall J, Hatton D, Beckett A, et al. Children’s accounts of attention deficit/hyperactivity disorder. Advances in Nursing Science. 2003;26:114–130. [PubMed: 12795540]

  • Kendall P, Braswell L. Cognitive Behavioural Therapy for Impulsive Children. New York: Guilford Press; 1982.

  • Kendall P, Finch A. A cognitive-behavioural treatment for impulsivity: a group comparison study. Journal of Consulting and Clinical Psychology. 1978;46:110–118. [PubMed: 342557]

  • Kendall P, Wilcox L. A cognitive-behavioural treatment for impulsivity: concrete versus conceptual training in non-self-controlled problem children. Journal of Consulting and Clinical Psychology. 1980;48:80–91. [PubMed: 7365047]

  • Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–18. [PubMed: 8279933]

  • Kessler RC, Merikangas KR, Berglund P. Mild disorders should not be eliminated from the DSM-V. Archives of General Psychiatry. 2003;60:1117–1122. [PubMed: 14609887]

  • Kessler RC, Adler L, Ames M, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. Journal of Occupational and Environmental Medicine. 2005;47:565–572. [PubMed: 15951716]

  • Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. American Journal of Psychiatry. 2006;163:716–723. [PMC free article: PMC2859678] [PubMed: 16585449]

  • King S, Waschbusch DA, Frankland BW, et al. Taxonomic examination of ADHD and conduct problem comorbidity in elementary school children using cluster analyses. Journal of Psychopathology and Behavioral Assessment. 2005;27:77–88.

  • King S, Griffin S, Hodges Z, et al. Assessment Report: Attention Deficit Hyperactivity Disorder – Methylphenidate, Atomoxetine and Dexamfetamine (Review). 2005. [accessed January 2008]. Available at: http://www​.nice.org.uk/guidance/index​.jsp?action​=download&o=33226.

  • King S, Griffin S, Hodges Z, et al. A Systematic Review and Economic Model of the Effectiveness and Cost-Effectiveness of Methylphenidate, Dexamfetamine and Atomoxetine for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents, Health Technology Assessment. Vol. 10. Tunbridge Wells: Gray Publishing; 2006. [PubMed: 16796929]

  • Klein C, Wendling K, Huettner P, et al. Intra-subject variability in attention-deficit hyperactivity disorder. Biological Psychiatry. 2006;60:1088–1097. [PubMed: 16806097]

  • Klein RG, Abikoff H. Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders. 1997;2:89–114.

  • Klein RG, Mannuzza S. Long-term outcome of hyperactive children: a review. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30:383–387. [PubMed: 2055874]

  • Kollins S, Greenhill L, Swanson J, et al. Rationale, design, and methods of the preschool ADHD treatment study (PATS). Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:1275–1283. [PubMed: 17023869]

  • Kooij JJS, Burger H, Boonstra AM, et al. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder: a randomised placebo-controlled double-blind cross-over trial. Psychological Medicine. 2004;34:973–982. [PubMed: 15554568]

  • Kooij JJ, Buitelaar JK, Van Der Oord EJ, et al. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychological Medicine. 2005;35:817–827. [PubMed: 15997602]

  • Korkman M, Kirk U, Kemp S. NEPSY: A Developmental Neuropsychological Assessment. San Antonio, Texas: Psychological Corporation; 1998.

  • Krueger RA, Casey MA. Focus Groups: A Practical Guide to Applied Research. London: Sage; 2000.

  • Kuntsi J, Eley TC, Taylor A, et al. Co-occurrence of ADHD and low IQ has genetic origins. American Journal of Medical Genetics. 2004;124B:41–47. [PubMed: 14681911]

  • Kupietz SS, Winsberg BG, Richardson E, et al. Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects. Journal of the American Academy of Child and Adolescent Psychiatry. 1988;27:70–77. [PubMed: 3343209]

  • Kurlan R, Goetz CG, McDermott MP, et al. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58:527–536. [PubMed: 11865128]

  • Lahey BB, Pelham WE, Schaughency EA, et al. Dimensions and types of attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1988;27:330–335. [PubMed: 3379015]

  • Lahey BB, Applegate K, McBurnett J, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. American Journal of Psychiatry. 1994;151:1673–1685. [PubMed: 7943460]

  • Lahti J, Raikkonen K, Kajantie E, et al. Small body size at birth and behavioural symptoms of ADHD in children aged five to six years. The Journal of Child Psychology and Psychiatry. 2006;47:1167–1174. [PubMed: 17076756]

  • Laing A, Aristides M. Attention Deficit Hyperactivity Disorder (ADHD) in Adults: SF–6D Utilities from SF–36 Scores in a Randomised trial. Poster presented at 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); 6–8 November 2005; Florence, Italy. 2005.

  • Lambert N. The contribution of childhood ADHD, conduct problems, and stimulant treatment to adolescent and adult tobacco and psychoactive substance abuse. Ethical Human Psychiatry and Psychology. 2005;7:197–221.

  • Larsson JO, Larsson H, Lichtenstein P. Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:1267–1275. [PubMed: 15381894]

  • Lee SS, Hinshaw SP. Severity of adolescent delinquency among boys with and without attention deficit hyperactivity disorder: predictions from early antisocial behavior and peer status. Journal of Clinical Child and Adolescent Psychology. 2004;33:705–716. [PubMed: 15498738]

  • Leibson CL, Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. The Journal of the American Medical Association. 2001;285:60–66. [PubMed: 11150110]

  • Lerer RJ, Lerer MP, Artner J. The effects of methylphenidate on the handwriting of children with minimal brain dysfunction. Journal of Pediatrics. 1977;91:127–32. [PubMed: 874649]

  • Leviton A, Guild-Wilson M, Neff RK, et al. The Boston teacher questionnaire. 1. Definition of syndromes. Journal of Child Neurology. 1993;8:43–53. [PubMed: 8445171]

  • Levy F, Dumbrell S, Hobbes G, et al. Hyperkinesis and diet: a double-blind crossover trial with a tartrazine challenge. The Medical Journal of Australia. 1978;1:61–64. [PubMed: 349320]

  • Levy F, Hay DA, McStephen M, et al. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:737–744. [PubMed: 9183127]

  • Li D, Sham PC, Owen MJ, et al. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Human Molecular Genetics. 2006;15:2276–2284. [PubMed: 16774975]

  • Liddel J, Williamson M, Irwig L. Method for Evaluating Research and Guideline Evidence. Sydney: New South Wales Health Department; 1996.

  • Linnet KM, Dalsgaard S, Obel C, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. American Journal of Psychiatry. 2003;160:1028–1040. [PubMed: 12777257]

  • Lloyd G, Stead J, Cohen D, editors. Critical New Perspectives on ADHD. London: Routledge; 2006.

  • Long N, Rickert VI, Ashcraft EW. Bibliotherapy as an adjunct to stimulant medication in the treatment of attention-deficit hyperactivity disorder. Journal of Pediatric Health Care. 1993;7:82–88. [PubMed: 8492283]

  • Lord J, Paisley S. The Clinical Effectiveness and Cost-Effectiveness of Methylphenidate for Hyperactivity in Childhood, Version 2. London: NICE; 2000.

  • Manly T, Robertson IH, Anderson V, et al. Test of Everyday Attention for Children. Bury St Edmunds: Thames Valley Test Company; 1998.

  • Mann T. Clinical Guidelines: Using Clinical Guidelines to Improve Patient Care Within the NHS. Leeds: NHS Executive; 1996.

  • Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up. Archives of General Psychiatry. 1991;48:77–83. [PubMed: 1984764]

  • Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Archives of General Psychiatry. 1993;50:565–576. [PubMed: 8317950]

  • Mannuzza S, Klein RG, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry. 1998;155:493–498. [PubMed: 9545994]

  • Mannuzza S, Klein RG, Moulton JL. Young adult outcome of children with ‘situational’ hyperactivity: a prospective, controlled follow-up study. Journal of Abnormal Child Psychology. 2002;30:191–198. [PubMed: 12008657]

  • Mannuzza S, Klein RG, Abikoff H, et al. Significance of childhood conduct problems to later development of conduct disorder among children with ADHD: a prospective follow-up study. Journal of Abnormal Child Psychology. 2004;32:565–573. [PubMed: 15500034]

  • Mannuzza S, Klein RG, Truong NL, et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. American Journal of Psychiatry. 2008;165:604–609. [PMC free article: PMC2967384] [PubMed: 18381904]

  • Marshall RM, Schafer VA, O’Donnell L, et al. Arithmetic disabilities and ADHD subtypes: implications for DSM-IV. Journal of Learning Disabilities. 1999;32:239–247. [PubMed: 15508243]

  • Martin NC, Piek JP, Hay D. DCD and ADHD: a genetic study of their shared aetiology. Human Movement Science. 2006;25:110–124. [PubMed: 16442650]

  • Mattes JA, Gittelman R. Effects of artificial food colorings in children with hyperactive symptoms: a critical review and results of a controlled study. Archives of General Psychiatry. 1981;38:714–718. [PubMed: 7247635]

  • Matza LS, Secnik K, Rentz AM, et al. Assessment of health states utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Quality of Life Research. 2005;14:735–747. [PubMed: 16022066]

  • Mautner VF, Kluwe L, Thakker SD, et al. Treatment of ADHD in neurofibromatosis type I. Developmental Medicine and Child Neurology. 2002;44:164–170. [PubMed: 12005317]

  • McArdle P, Prosser J, Kolvin I. Prevalence of psychiatric disorder: with and without psychosocial impairment. European Child and Adolescent Psychiatry. 2004;13:347–353. [PubMed: 15619046]

  • McCann D, Barrett A, Cooper A, et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blind, placebo-controlled trial. The Lancet. 2007;3:1560–1567. [PubMed: 17825405]

  • McDonagh MS, Peterson K, Dana T, et al. Drug Class Review on Pharmacologic Treatments for ADHD. 2007. [accessed July 2008]. Available at: http://www​.ohsu.edu/drugeffectiveness​/reports/final.cfm. [PubMed: 20480923]

  • McElearney C, Fitzpatrick C, Farrell N, et al. Stimulant medication in ADHD: what do children and their parents say? Irish Journal of Psychological Medicine. 2005;22:5–9. [PubMed: 30308749]

  • McGee R, Williams S, Bradshaw J, et al. The Rutter scale for completion by teachers: factor structure and relationships with cognitive abilities and family adversity for a sample of New Zealand children. The Journal of Child Psychology and Psychiatry. 1985;26:727–739. [PubMed: 4044718]

  • McGee R, Williams S, Feehan M. Attention deficit disorder and age of onset of problem behaviors. Journal of Abnormal Child Psychology. 1992;20:487–502. [PubMed: 1487592]

  • McGee R, Prior M, Williams S, et al. The long-term significance of teacher-rated hyperactivity and reading ability in childhood: findings from two longitudinal studies. The Journal of Child Psychology and Psychiatry. 2002;43:1004–1017. [PubMed: 12455922]

  • McLeer SV, Callaghan M, Henry D, et al. Psychiatric disorders in sexually abused children. Journal of the American Academy of Child and Adolescent Psychiatry. 1994;33:313–319. [PubMed: 8169175]

  • Meaux J, Hester C, Smith B, et al. Stimulant medications: a trade-off? The lived experience of adolescents with ADHD. Journal for Specialists in Pediatric Nursing. 2006;11:214–226. [PubMed: 16999743]

  • Meichenbaum D. Cognitive Behaviour Modification: An Integrative Approach. New York: Plenum; 1977.

  • Meichenbaum D, Goodman J. Training impulsive children to talk to themselves: a means of developing self-control. Journal of Abnormal Psychology. 1971;77:115–126. [PubMed: 5550424]

  • Meo A, Parker A. Teachers, teaching and educational exclusion: pupil referral units and pedagogic practice. International Journal of Inclusive Education. 2004;8:103–120.

  • Merrell C, Tymms P. Inattention, hyperactivity and impulsiveness: their impact on academic achievement and progress. British Journal of Educational Psychology. 2001;71:43–56. [PubMed: 11307708]

  • Merrell C, Tymms P. Working with Difficult Children in Years 1 and 2: A Guide for Teachers. Durham: CEM Centre, University of Durham; 2002.

  • Merrell C, Tymms P. Rasch analysis of inattentive, hyperactive and impulsive behaviour in young children and the link with academic achievement. Journal of Applied Measurement. 2005;6:1–18. [PubMed: 15701941]

  • Merrell C, Tymms P. A Longitudinal Study of the Achievements, Progress and Attitudes of Severely Inattentive, Hyperactive and Impulsive Young Children. Paper presented at the Annual Conference of the British Educational Research Association, University of Glamorgan; September 2005. 2005.

  • MHRA . Zyban (bupropion hydrochloride) – safety update. Jul 26, 2002. [accessed April 2008]. Available at: http://www​.mhra.gov.uk​/Safetyinformation​/Safetywarningsalertsandrecalls​/Safetywarningsandmessagesformedicines/CON2015725.

  • Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108:E83. [PubMed: 11694667]

  • Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. American Journal of Psychiatry. 2002;159:1896–1901. [PubMed: 12411225]

  • Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biological Psychiatry. 2003;53:112–120. [PubMed: 12547466]

    This is the reference for MICHELSON2003A and MICHELSON2003B.

  • Michelson D, Buitelaar JK, Danckaerts M, et al. Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:896–904. [PubMed: 15213591]

  • Mick E, Biederman J, Faraone SV, et al. Case-control study of attention deficit hyperactivity disorder and maternal smoking, alcohol use and drug use during pregnancy. American Journal of Child and Adolescent Psychiatry. 2002;41:378–385. [PubMed: 11931593]

  • Moffitt TE. Juvenile delinquency and attention deficit disorder: boys’ developmental trajectories from age 3 to 15. Child Development. 1990;61:893–910. [PubMed: 2364762]

  • Moffitt TE, Caspi A, Rutter M. Strategy for investigating interactions between measured genes and measured environments. Archives of General Psychiatry. 2005;62:473–481. [PubMed: 15867100]

  • Molina BSG, Pelham WE. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. Journal of Abnormal Psychology. 2003;112:497–507. [PubMed: 12943028]

  • Molina BSG, Smith BH, Pelham WE. Factor structure and criterion validity of secondary school teacher ratings of ADHD and ODD. Journal of Abnormal Child Psychology. 2001;29:71–82. [PubMed: 11316336]

  • Molina BSG, Flory K, Hinshaw SP, et al. Delinquent behaviour and emerging substance use in MTA at 36 months: prevalence, course, and treatment effects. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:1–11. [PubMed: 17667481]

  • Mortimore P, Sammons P, Stoll L, et al. School Matters: The Junior Years. Wells, Somerset: Open Books; 1988.

  • MTA Co-operative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry. 1999;56:1073–1086. [PubMed: 10591283]

  • MTA Co-operative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry. 1999;56:1088–1096. [PubMed: 10591284]

  • MTA Co-operative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry. 2004;56:1088–1096. [PubMed: 15060224]

  • MTA Co-operative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004;113:762–769. [PubMed: 15060225]

  • Muthukrishna N. Inclusion and exclusion in school: experiences of children labelled ‘ADHD’ in South Africa, Critical New Perspectives on ADHD. Lloyd G, Stead J, Cohen D, editors. Abingdon: Routledge; 2006. pp. 96–114.

  • Nadder TS, Rutter M, Silberg JL, et al. Genetic effects on the variation and covariation of attention deficit-hyperactivity disorder (ADHD) and oppositional-defiant disorder/conduct disorder (ODD/CD) symptomatologies across informant and occasion of measurement. Psychological Medicine. 2002;32:39–53. [PubMed: 11883729]

  • Narayan S, Hay J. Cost effectiveness of methylphenidate versus AMP/DEX mixed salts for the first-line treatment of ADHD. Expert Review of Pharmacoeconomics and Outcomes Research. 2004;4:625–634. [PubMed: 19807536]

  • National Institutes of Health. NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder; 16–18 November; William H. Natcher Conference Centre National Institutes of Health; Bethesda Maryland. 1998.

  • Neuman RJ, Lobos E, Reich W, et al. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biological Psychiatry. 2007;61:1320–1328. [PubMed: 17157268]

  • Newcorn JH, Michelson D, Kratochvil CJ, et al. Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder. Pediatrics. 2006;118:e1701–e1706. [PubMed: 17101710]

  • Newcorn JH, Kratochvil C, Allen AJ, et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. American Journal of Psychiatry. 2008;165:721–730. [PubMed: 18281409]

  • NHS Health and Social Care Information Centre . Prescription Cost Analysis England 2005. London: NHS Health and Social Care Information Centre, Health Care Statistics; 2006.

  • NHS Information Centre . Prescription Cost Analysis England 2006. London: NHS Information Centre, Prescribing Support Unit; 2007.

  • NICE. Guide to the Methods of Technology Appraisal National Institute for Clinical Excellence. London: NICE; 2004. Available from: www​.nice.org.uk. [PubMed: 27905712]

  • NICE and SCIE. Technology Appraisal 102. London: NICE; 2006. Parent-Training/Education Programmes in the Management of Children with Conduct Disorders. Available at: www​.nice.org.uk/TA102.

  • NICE. Technology Appraisal 98. London: NICE; 2006. Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Available at: www​.nice.org.uk/TA98.

  • NICE. The Guidelines Manual. London: NICE; 2006. Available from: www​.nice.org.uk.

  • Novartis Pharmaceuticals UK Ltd . Ritalin. Summary of Product Characteristics. 2007. Available at: http://emc​.medicines.org.uk.

  • Nussbaum NL, Grant ML, Roman MJ, et al. Attention deficit and the mediating effect of age on academic and behavioural variables. Journal of Behavioural and Developmental Pediatrics. 1990;11:22–26. [PubMed: 2303554]

  • O’Connor TG, Heron J, Golding J, et al. Maternal antenatal anxiety and children’s behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. British Journal of Psychiatry. 2002;180:502–508. [PubMed: 12042228]

  • O’Connor TG, Heron J, Golding J, et al. Maternal antenatal anxiety and behavioural/emotional problems in children: a test of a programming hypothesis. The Journal of Child Psychology and Psychiatry. 2003;44:1025–1036. [PubMed: 14531585]

  • Office for National Statistics. T 03: England and Wales; Estimated Resident Population by Single Year of Age and Sex; Mid–2006 Population Estimates. London: Office for National Statistics; 2007. Available from: http://www​.statistics​.gov.uk/statbase/ssdataset​.asp?vlnk=9659&More=Y.

  • Olfson M, Gameroff MJ, Marcus SC, et al. National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry. 2003;160:1071–1077. [PubMed: 12777264]

  • Ornoy A, Segal J, Bar-Hamburger R, et al. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Developmental Medicine and Child Neurology. 2001;43:668–675. [PubMed: 11665823]

  • O’Shaughnessy T, Lane K, Gresham F, et al. Children placed at risk for learning and behavioural difficulties: implementing a school-wide system of early identification and intervention. Remedial and Special Education. 2003;24:27–35.

  • Owens EB, Hinshaw SP, Kraemer HC, et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. Journal of Consulting and Clinical Psychology. 2003;71:540–552. [PubMed: 12795577]

  • Paloyelis Y, Mehta MA, Kuntsi J, et al. Functional MRI in ADHD: a systematic literature review. Expert Review of Neurotherapeutics. 2007;7:1337–1356. [PMC free article: PMC3763932] [PubMed: 17939771]

  • Palumbo D, Spencer T, Lynch J, et al. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy. Journal of Child and Adolescent Psychopharmacology. 2004;14:185–194. [PubMed: 15319016]

  • Paterson R, Douglas C, Hallmayer J, et al. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry. 1999;33:494–502. [PubMed: 10483843]

  • Pelham WE. The effects of psychostimulant drugs on learning and academic achievement in children with attention-deficit hyperactivity disorders and learning disabilities, Psychological and Educational Perspectives on Learning Disabilities. Torgesen JK, Wong B, editors. New York: Academic Press; 1986. pp. 259–295.

  • Pelham WE, Gnagy EM. Psychosocial and combined treatments. Mental Retardation and Developmental Disabilities Research Reviews. 1999;5:225–236.

  • Pelham WE, Murphy HA. Attention deficit and conduct disorder, Pharmacological and Behavioural Treatment: an Integrative Approach. Hersen M, editor. New York: John Wiley & Sons; 1986. pp. 108–148.

  • Pelham WE, Gnagy EM, Greenslade KE, et al. Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31:210–218. [PubMed: 1564021]

  • Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Journal of Pediatric Psychology. 2007;32:711–727. [PubMed: 17556402]

  • Perring C. Medicating children: the case of Ritalin. Bioethics. 1997;11:228–240. [PubMed: 11654776]

  • Pfiffner LJ, McBurnett K. Social skills training with parent generalization: treatment effects for children with attention deficit disorder. Journal of Consulting and Clinical Psychology. 1997;65:749–757. [PubMed: 9337494]

  • Philbrick D, Tymms P, Woodcock S, editors. A Multi-Agency Approach to Difficulties Associated with Attention, Hyperactivity and Impulsiveness: Framework and Guidance 2004. Durham: Durham County Council, NHS, CEM Centre; 2004.

  • Pillow DR, Pelham WE, Hoza B, et al. Confirmatory factor analyses examining attention deficit hyperactivity disorder symptoms and other childhood disruptive behaviors. Journal of Abnormal Child Psychology. 1998;26:293–309. [PubMed: 9700521]

  • Pineda DA, Lopera F, Palacio JD, et al. Prevalence estimations of attention-deficit/hyperactivity disorder: differential diagnoses and comorbidities in a Colombian sample. International Journal of Neuroscience. 2003;113:49–71. [PubMed: 12691001]

  • Pliszka SR, Browne RG, Olvera RL, et al. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:619–626. [PubMed: 10802980]

  • Pliszka SR, Glahn DC, Semrud-Clikeman M, et al. Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. American Journal of Psychiatry. 2006;163:1052–1060. [PubMed: 16741206]

  • Poduska JM. Parents’ perceptions of their first graders’ need for mental health and educational services. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:584–591. [PubMed: 10802976]

  • Pol AC, Verhulst FC, van der Ende J, et al. Classes of disruptive behaviour in a sample of young elementary school children. The Journal of Child Psychology and Psychiatry. 2003;44:377–387. [PubMed: 12635967]

  • Polanczyk G, Silva de Lima M, Horta BH, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry. 2007;164:942–948. [PubMed: 17541055]

  • Poulton A. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder. Current Opinion in Pediatrics. 2006;18:427–434. [PubMed: 16914999]

  • Power TJ, Hess LE, Bennett DS. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers. Journal of Developmental and Behavioral Pediatrics. 1995;16:238–243. [PubMed: 7593658]

  • Pratt TC, Cullen FT, Blevins KR, et al. The relationship of attention deficit hyperactivity disorder to crime and delinquency: a meta-analysis. International Journal of Police Science and Management. 2002;4:344–360.

  • Price TS, Simonoff E, Waldman I, et al. Hyperactivity in preschool children is highly heritable. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:1362–1364. [PubMed: 11765277]

  • Price TS, Simonoff E, Asherson P, et al. Continuity and change in preschool ADHD symptoms: longitudinal genetic analysis with contrast effects. Behavior Genetics. 2005;35:121–132. [PubMed: 15685426]

  • Prosser B. ADHD: Who’s Failing Who? Sydney: Finch Publishing; 2006.

  • Psychogiou L, Daley DM, Thompson MJ, et al. Mothers’ expressed emotion toward their school-aged sons. Associations with child and maternal symptoms of psychopathology. European Child and Adolescent Psychiatry. 2007;16:458–464. [PubMed: 17876512]

  • Purdie N, Hattie J, Carroll A. A review of the research on interventions for attention deficit hyperactivity disorder: what works best? Review of Educational Research. 2002;72:61–99.

  • Rabinowitz E. Recreation interventions for individuals with attention deficit hyperactivity disorder. American Journal of Recreation Therapy. 2004;3:31–35.

  • Ramsay JR, Rostain AL. A cognitive therapy approach for adult attention deficit/hyperactivity disorder. Journal of Cognitive Psychotherapy: an International Quarterly. 2003;17:319–333.

  • Rapoport JL. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science. 1978;199:560–563. [PubMed: 341313]

  • Rasmussen ER, Neuman RJ, Heath AC, et al. Familial clustering of latent class and DSM-IV defined attention-deficit/hyperactivity disorder (ADHD) subtypes. The Journal of Child Psychology and Psychiatry. 2004;45:589–598. [PubMed: 15055377]

  • Read J. Why promoting biological ideology increases prejudice against people labeled ‘schizophrenic’ Australian Psychologist. 2007;42:118–128.

  • Reimherr FW, Hedges DW, Strong RE, et al. Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial. Neuropsychiatric Disease and Treatment. 2005;1:245–251. [PMC free article: PMC2416755] [PubMed: 18568102]

  • Rey JM, Walter G, Plapp JM, et al. Family environment in attention deficit hyperactivity, oppositional defiant and conduct disorders. Australian and New Zealand Journal of Psychiatry. 2000;34:453–457. [PubMed: 10881969]

  • Rhodes SM, Coghill DR, Matthews K. Acute neuropsychological effects of methylphenidate in stimulant drug-naive boys with ADHD II: broader executive and non-executive domains. The Journal of Child Psychology and Psychiatry. 2006;47:1184–1194. [PubMed: 17076758]

  • Richardson A. Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Biomedical and Life Sciences. 2004;39:1215–1222. [PubMed: 15736918]

  • Richardson AJ, Montgomery P. The Oxford–Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005;115:1360–1366. [PubMed: 15867048]

  • Richardson A, Puri B. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning disabilities. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002;26:233–239. [PubMed: 11817499]

  • Rieppi R, Greenhill LL, Ford RE, et al. Socioeconomic status as a moderator of ADHD treatment outcomes. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41:269–277. [PubMed: 11886021]

  • Rietveld MJH, Hudziak JJ, Bartels M, et al. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. The Journal of Child Psychology and Psychiatry. 2004;45:577–588. [PubMed: 15055376]

  • Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–1517. [PubMed: 8801636]

  • Robertson IH, Ward T, Ridgeway V, et al. The Test of Everyday Attention. Bury St Edmunds: Thames Valley Test Company; 1994.

  • Robins LN, Helzer JE, Croughan J, et al. National Institute of Mental Health diagnostic interview schedule: its history, characteristics and validity. Archives of General Psychiatry. 1981;38:381–389. [PubMed: 6260053]

  • Rodriguez A, Bohlin G. Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? The Journal of Child Psychology and Psychiatry. 2005;46:246–254. [PubMed: 15755301]

  • Ronald A, Simonoff E, Kuntsi J, et al. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. The Journal of Child Psychology and Psychiatry. 2008;49:535–542. [PubMed: 18221348]

  • Rosenhan D. On being sane in insane places. Science. 1973;179:250–258. [PubMed: 4683124]

  • Rosenman S. Reconsidering the attention deficit paradigm. Australasian Psychiatry. 2006;14:127–132. [PubMed: 16734638]

  • Rosler M, Retz W, Retz-Junginger P, et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. European Archives of Psychiatry and Clinical Neuroscience. 2004;254:365–371. [PubMed: 15538605]

  • Rosvold HE, Mirsky AF, Sarason I, et al. A continuous performance test of brain damage. Journal of Consulting Psychology. 1956;20:343–350. [PubMed: 13367264]

  • Roy P, Rutter M, Pickles A. Institutional care: risk from family background or pattern of rearing? The Journal of Child Psychology and Psychiatry. 2000;41:139–149. [PubMed: 10750540]

  • Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatric Neurology. 2003;29:136–142. [PubMed: 14580657]

  • Rutter M, O’Connor TG. Are there biological programming effects for psychological development? Findings from a study of Romanian adoptees. Developmental Psychology. 2004;40:81–94. [PubMed: 14700466]

  • Rutter M, Cox A, Tupling C, et al. Attainment and adjustment in two geographical areas. I: the prevalence of psychiatric disorder. British Journal of Psychiatry. 1975;126:493–509. [PubMed: 1174767]

  • Rutter M, Maughan B, Mortimer P, et al. Fifteen Thousand Hours. London: Open Books; 1979.

  • Safren SA, Otto MW, Sprich S, et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy. 2005;43:831–842. [PubMed: 15896281]

  • Sanders MR, Mazzucchelli TG, Studman L. Stepping Stones Triple P – An evidence-based positive parenting program for families with a child who has a disability: its theoretical basis and development. Journal of Intellectual and Developmental Disability. 2004;29:1–19.

  • San Roman P. Multi-agency assessment pathway approach to difficulties of attention/overactivity (including AD/HD): a community pilot. National ADHD Conference ; Edinburgh: University of Edinburgh; 2007.

  • Santosh PJ, Taylor E, Swanson J, et al. Refining the diagnoses of inattention and overactivity syndromes: a reanalysis of the multimodal treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD–10 criteria for hyperkinetic disorder. Clinical Neuroscience Research. 2005;5:307–314.

  • Satterfield JH, Dawson ME. Electrodermal correlates of hyperactivity in children. Psychophysiology. 1971;8:191. [PubMed: 5089415]

  • Satterfield JH, Schell A. A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1726–1735. [PubMed: 9401334]

  • Satterfield JH, Cantwell DP, Saul RE, et al. Response to stimulant drug treatment in hyperactive children: prediction from EEG and neurological findings. Journal of Autism and Childhood Schizophrenia. 1973;3:35–48. [PubMed: 4740584]

  • Satterfield J, Swanson J, Schell A, et al. Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores. Journal of the American Academy of Child and Adolescent Psychiatry. 1994;33:185–190. [PubMed: 8150789]

  • Sayal K, Taylor E, Beecham J, et al. Pathways to care in children at risk of attention-deficit hyperactivity disorder. The British Journal of Psychiatry. 2002;181:43–48. [PubMed: 12091262]

  • Sayal K, Goodman R, Ford T. Barriers to the identification of children with attention deficit/hyperactivity disorder. The Journal of Child Psychology and Psychiatry. 2006;47:744–750. [PubMed: 16790009]

  • Sayal K, Hornsey H, Warren S, et al. Identification of children at risk of attention deficit/hyperactivity disorder: a school-based intervention. Social Psychiatry and Psychiatric Epidemiology. 2006;41:806–813. [PubMed: 16841146]

  • Schab DW, Trinh NHT. Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials. Journal of Developmental and Behavioral Pediatrics. 2004;25:423–434. [PubMed: 15613992]

  • Schacher R, Tannock R. Syndromes of hyperactivity and attention deficit, Child and Adolescent Psychiatry. 4th edn. Rutter M, Taylor E, editors. Oxford: Blackwell; 2002. pp. 399–418.

  • Schachar RJ, Tannock R, Cunningham C, et al. Behavioral, situational and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:754–763. [PubMed: 9183129]

  • Scheff T. Labelling mental illness, Mental Health Matters. Heller TC, editor. London: Macmillan; 1975.

  • Schlander M. Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription drug spending for children and adolescents: increasing relevance of health economic evidence. Child and Adolescent Psychiatry and Mental Health. 2007;1 [PMC free article: PMC2216002] [PubMed: 18005403] [CrossRef]

  • Schlander M, Schwartz O, Hakkart-van Roijen L, et al. Cost-Effectiveness of Clinical Proven Treatment Strategies for Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States, Germany, The Netherlands, Sweden, and United Kingdom. Poster presented at 9th Annual European meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); 29–31 October 2006; Copenhagen, Denmark. 2006.

  • Schlander M, Schwartz O, Hakkart-van Roijen L, et al. Functional Impairment of Patients with Attention-Deficit/Hyperactivity Disorder (ADHD): An Alternative Cost-Effectiveness Analysis of Clinically Proven Treatment Strategies Based upon the NIMH MTA Study. Poster presented at 9th Annual European meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); 29–31 October 2006; Copenhagen, Denmark. 2006.

  • Schlander M, Schwartz O, Foster EM, et al. Cost-Effectiveness of Clinically Proven Treatment Strategies for Attention-Deficit/Hyperactivity Disorder (ADHD): Impact of Co-existing Conditions. Poster presented at 9th Annual European meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); 29–31 October 2006; Copenhagen, Denmark. 2006.

  • Schmidt MH, Mocks P, Lay B, et al. Does oligoantigenic diet influence hyperactive/conduct-disordered children: a controlled trial. European Child and Adolescent Psychiatry. 1997;6:88–95. [PubMed: 9257090]

  • Schmitt B. The minimal brain dysfunction myth. American Journal of Diseases of Children. 1975;129:1313–1318. [PubMed: 1190163]

  • Schoechlin C, Engel RR. Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data. Archives of Clinical Neuropsychology. 2005;20:727–744. [PubMed: 15953706]

  • Schwab-Stone M, Fisher P, Piacentini J, et al. The Diagnostic Interview Schedule for Children-Revised Version (DISC-R): II. Test-retest reliability. Journal of the American Academy of Child and Adolescent Psychiatry. 1993;32:651–657. [PubMed: 8496129]

  • Schwab-Stone M, Fallon T, Briggs M, et al. Reliability of diagnostic reporting for children aged 6–11 years: a test-retest study of the Diagnostic Interview Schedule for Children-Revised. American Journal Psychiatry. 1994;151:1048–1054. [PubMed: 8010363]

  • Sciutto MJ, Terjesen MD, Frank ASB. Teachers’ knowledge and misperceptions of attention-deficit/hyperactivity disorder. Psychology in the Schools. 2000;37:115–122.

  • Scott S. Parent training programmes, Child and Adolescent Psychiatry. 4th edn. Rutter M, Taylor E, editors. Oxford: Blackwell; 2002. pp. 949–967.

  • Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics. 2005;23:93–102. [PubMed: 15693731]

  • Secnik K, Matza LS, Cottrell S, et al. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United Kingdom. Medical Decision Making. 2005;25:56–70. [PubMed: 15673582]

  • Silberg J, Rutter M, Meyer J, et al. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. The Journal of Child Psychology and Psychiatry. 1996;37:803–816. [PubMed: 8923223]

  • Singh I. Boys will be boys: fathers’ perspectives on ADHD symptoms, diagnosis, and drug treatment. Harvard Review of Psychiatry. 2003;11:308–316. [PubMed: 14713567]

  • Singh I. Doing their jobs: mothering with Ritalin in a culture of mother-blame. Social Science and Medicine. 2004;59:1193–1205. [PubMed: 15210091]

  • Singh I. Will the ‘real boy’ please behave: dosing dilemmas for parents of boys with ADHD. The American Journal of Bioethics. 2005;5:1–14. [PubMed: 16006369]

  • Singh I. A framework for understanding trends in ADHD diagnosis and stimulant drug treatment: school and schooling as a case study. BioSocieties. 2006;1:439–452.

  • Singh I. Capacity and competence in children as research participants. EMBO Reports. 2007;8:35–39. [PMC free article: PMC3327530] [PubMed: 17726441]

  • Smith EV Jr, Johnson BD. Attention deficit hyperactivity disorder: scaling and standard setting using Rasch measurement. Journal of Applied Psychological Measurement. 2000;1:3–24. [PubMed: 12023555]

  • Sonuga-Barke EJS. Categorical model in child psychopathology: a conceptual and empirical analysis. The Journal of Child Psychology and Psychiatry. 1998;39:115–133. [PubMed: 9534089]

  • Sonuga-Barke EJ. The dual pathway model of AH/HD: an elaboration of neuron-developmental characteristics. Neuroscience and Biobehavioural Reviews. 2003;27:593–604. [PubMed: 14624804]

  • Sonuga-Barke EJ, Minocha K, Taylor EA, et al. Inter-ethnic bias in teachers’ ratings of childhood hyperactivity. British Journal of Developmental Psychology. 1993;11:187–200.

  • Sonuga-Barke EJ, Daley D, Thompson M, et al. Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:402–408. [PubMed: 11314565]

  • Sorensen E. Qualitative research with children as informants. Communicating Nursing Research. 1992;25:328.

  • Sparks GM. The effectiveness of alternative training activities in changing teaching practices. American Educational Research Journal. 1986;23:217–225.

  • Spencer TJ, Biederman J, Harding M, et al. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:1460–1469. [PubMed: 8936912]

  • Spencer T, Heiligenstein JH, Biederman J, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry. 2002;63:1140–1147. [PubMed: 12523874]

    This is the reference for SPENCER2002A, 2002B and 2002C.

  • Spencer T, Biederman J, Wilens T, et al. A large, double-blind, randomised clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biological Psychiatry. 2005;57:456–463. [PubMed: 15737659]

  • Sprague RL, Werry JS. Methodology of psychopharmacological studies with the retarded, International Review of Research in Mental Retardation. Ellis NR, editor. Vol. 5. New York: Academic Press; 1971. pp. 148–220.

  • Sprich S, Biederman J, Crawford MH, et al. Adoptive and biological families of children and adolescents with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:1432–1437. [PubMed: 11068899]

  • Sterman MB. Physiological origins and functional correlates of EEG-rhythmic activities: implications for self-regulation. Biofeedback and Self-Regulation. 1996;21:3–33. [PubMed: 8833314]

  • Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003;38:1007–1021. [PubMed: 14669965]

  • Stevens SE, Sonuga-Barke EJ, Kreppner JM, et al. Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence. Journal of Abnormal Child Psychology. 2008;36:385–398. [PubMed: 17965931]

  • Stevenson CS, Whitmont S, Bornholt L, et al. A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry. 2002;36:610–616. [PubMed: 12225443]

  • Stevenson CS, Stevenson RJ, Whitmont S. A self-directed psychosocial intervention with minimal therapist contact for adults with attention deficit hyperactivity disorder. Clinical Psychology and Psychotherapy. 2003;10:93–101.

  • Stier A, Hinshaw S. Explicit and implicit stigma against individuals with mental illness. Australian Psychologist. 2007;42:106–117.

  • Stoops WW, Glaser PE, Fillmore MT, et al. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. Journal of Psychopharmacology. 2004;18:534–543. [PubMed: 15582920]

  • Stowe CD, Gardner SF, Gist CC, et al. 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy. The Annals of Pharmacotherapy. 2002;36:1142–1149. [PubMed: 12086544]

  • Swanson JM, McBurnett K, Wigal T, et al. Effect of stimulant medication on children with attention deficit hyperactivity disorder: a review of reviews. Exceptional Children. 1993;60:154–162.

  • Swanson JM, McBurnett K, Christian DL, et al. Stimulant medication and treatment of children with ADHD, Advances in Clinical Child Psychology. Ollendick TH, Prinz RJ, editors. Vol. 17. New York: Plenum Press; 1995. pp. 265–322.

  • Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:168–179. [PubMed: 11211365]

  • Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomised, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. Journal of Clinical Psychiatry. 2006;67:137–147. [PubMed: 16426100]

  • Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:1014–1026. [PubMed: 17667480]

  • Swensen AR, Birnbaum HG, Secnik K, et al. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:1415–1423. [PubMed: 14627876]

  • Talge NM, Neal C, Glover V. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? The Journal of Child Psychology and Psychiatry. 2007;48:245–261. [PubMed: 17355398]

  • Taylor E. Overactivity, hyperactivity and hyperkinesis: problems and prevalence, The Overactive Child: Clinics in Developmental Medicine. Taylor E, editor. Vol. 97. London & Oxford: Mac Keith Press& Blackwell; 1986.

  • Taylor E, Sandberg S. Hyperactive behavior in English schoolchildren: a questionnaire survey. Journal of Abnormal Child Psychology. 1984;12:143–156. [PubMed: 6715689]

  • Taylor E, Sonuga-Barke E. Disorders of attention and activity, Rutter’s Child and Adolescent Psychiatry. 5th edn. Rutter M, Taylor E, Stevenson JS, et al., editors. London: Blackwell; 2008.

  • Taylor EA, Schachar R, Thorley G, et al. Conduct disorder and hyperactivity: I. Separation of hyperactivity and antisocial conduct in British child psychiatric patients. British Journal of Psychiatry. 1986;149:760–767. [PubMed: 3790875]

  • Taylor E, Sandberg S, Thorley G, et al. The Epidemiology of Childhood Hyperactivity. Oxford; Oxford University Press; 1991.

  • Taylor E, Chadwick O, Heptinstall E, et al. Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:1213–1226. [PubMed: 8824065]

  • Taylor E, Doepfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder: first upgrade. European Child and Adolescent Psychiatry. 2004;13(Suppl 1):1–30. [PubMed: 15322953]

  • Thapar A, Holmes J, Poulton K, et al. Genetic basis of attention deficit and hyperactivity. British Journal of Psychiatry. 1999;174:105–111. [PubMed: 10211163]

  • Thapar A, Harrington R, McGuffin P. Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design. British Journal of Psychiatry. 2001;179:224–229. [PubMed: 11532799]

  • Thompson AL, Molina BS, Pelham W Jr, et al. Risky driving in adolescents and young adults with childhood ADHD. Journal of Pediatric Psychology. 2007;32:745–759. [PubMed: 17442694]

  • Thorell L. Do delay aversion and executive function deficits make distinct contributions to the functional impact of ADHD symptoms? A study of early academic skills deficits. The Journal of Child Psychology and Psychiatry. 2007;48:1061–1070. [PubMed: 17995481]

  • Timimi S. Why diagnosis of ADHD has increased so rapidly in the west: a cultural perspective, Rethinking ADHD. Timimi S, Lee J, editors. Hampshire: Palgrave Macmillan; 2006.

  • Toren P, Eldar S, Sela BA, et al. Zinc deficiency in attention deficit hyperactivity disorder. Biological Psychiatry. 1996;40:1308–1310. [PubMed: 8959299]

  • Tutty S, Gephart H, Wurzbacher K. Enhancing behavioral and social skill functioning in children newly diagnosed with attention-deficit hyperactivity disorder in a pediatric setting. Journal of Developmental and Behavioral Pediatrics. 2003;24:51–57. [PubMed: 12584485]

  • Tymms P, Merrell C. The impact of screening and advice on inattentive, hyperactive and impulsive children. European Journal of Special Needs Education. 2006;21:321–337.

  • UCB Pharma Limited . Dexedrine Tablets 5 mg. Summary of Product Characteristics. 2005. Available at: http://emc​.medicines.org.uk.

  • UCB Pharma Limited . Equasym 5 mg, 10 mg and 20 mg Tablets. Summary of Product Characteristics. 2006. Available at: http://emc​.medicines.org.uk.

  • UCB Pharma Limited . Equasym XL 10 mg, 20 mg or 30 mg Capsules. Summary of Product Characteristics. 2008. Available at: http://emc​.medicines.org.uk.

  • Urbano FJ, Leznik E, Llinás RR. Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:12554–12559. [PMC free article: PMC1925036] [PubMed: 17640897]

  • Valera E, Faraone S, Murray K, et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biological Psychiatry. 2007;61:1361–1369. [PubMed: 16950217]

  • Van den Bergh BR, Marcoen A. High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Development. 2004;75:1085–1097. [PubMed: 15260866]

  • Van Lier PAC, Verhulst FC, van der Ende J, et al. Classes of disruptive behaviour in a sample of young elementary school children. The Journal of Child Psychology and Psychiatry. 2003;44:377–387. [PubMed: 12635967]

  • Verhulst FC, van der Ende J. Rating scales, Child and Adolescent Psychiatry. Rutter M, Taylor E, editors. Oxford: Blackwell; 2002. pp. 70–86.

  • Villalba L. Safety Review: Sudden Death with Drugs Used to Treat ADHD. 2006. Available at: http://www​.fda.gov/OHRMS​/DOCKETS/AC/06/briefing​/2006-4210b_07_01_safetyreview​.pdf.

  • Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. Journal of Pediatrics. 2001;139:189–196. [PubMed: 11487742]

  • Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry. 1998;155:1325–1331. [PubMed: 9766762]

  • Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry. 2004;161:1173–1180. [PubMed: 15229048]

  • Wallander JL, Schmitt M, Koot HM. Quality of life measurement in children and adolescents: issues, instruments, and applications. Journal of Clinical Psychology. 2001;57:571–585. [PubMed: 11255207]

  • Walter HJ, Gouze K, Lim KG. Teachers’ beliefs about mental health needs in inner city elementary schools. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:61–68. [PubMed: 16327582]

  • Wang Y, Zheng Y, Du Y, et al. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Australian and New Zealand Journal of Psychiatry. 2007;41:222–230. [PubMed: 17464703]

  • Webster-Stratton C. Videotape modeling: a method of parent education. Journal of Clinical Child Psychology. 1981;10:93–98.

  • Weiss G, Hechtman LT. Hyperactive Children Grown Up: ADHD in Children, Adolescents and Adults. 2nd edn. New York: Guilford Press; 1993.

  • Weiss G, Kruger E, Danielson U, et al. Effect of long-term treatment of hyperactive children with methylphenidate. Canadian Medical Association Journal. 1975;112:159–165. [PMC free article: PMC1956418] [PubMed: 803405]

  • Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal. 2003;168:715–722. [PMC free article: PMC154919] [PubMed: 12642429]

  • Weiss M, Trokenberg-Hechtman L, Weiss G. ADHD in Adulthood: a Guide to Current Theory, Diagnosis, and Treatment. Baltimore: Johns Hopkins University Press; 1999.

  • Weiss M, Tannock R, Kratochvil C, et al. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2005;44:647–655. [PubMed: 15968233]

  • Wells KC, Pelham WE, Kotkin RA, et al. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology. 2000;28:483–505. [PubMed: 11104313]

  • Wender PH. Attention-deficit hyperactivity disorder in adults. Psychiatric Clinics of North America. 1998;21:761–774. [PubMed: 9890120]

  • Wernicke JF, Faries D, Girod D, et al. Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Safety. 2003;26:729–740. [PubMed: 12862507]

  • Wernicke JF, Adler L, Spencer T, et al. Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment. Journal of Clinical Psychopharmacology. 2004;24:30–35. [PubMed: 14709944]

    This is the reference for WERNICKE2004A and 2004B.

  • Werry JS, Sprague RL, Cohen MN. Conners’ teacher rating scale for use in drug studies with children: an empirical study. Journal of Abnormal Child Psychology. 1975;3:217–229. [PubMed: 1214032]

  • Whalen CK, Henker B. Therapies for hyperactive children: comparisons, combinations, and compromises. Journal of Consulting and Clinical Psychology. 1991;59:126–137. [PubMed: 2002128]

  • Whalen CK, Henker B, Collins BE, et al. A social ecology of hyperactive boys: medication effects in structured classroom environments. Journal of Applied Behavior Analysis. 1979;12:65–81. [PMC free article: PMC1311350] [PubMed: 468749]

  • Whiting PF, Rutjes AWS, Reitsma JB, et al. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Annals of Internal Medicine. 2004;140:189–202. [PubMed: 14757617]

  • Wilcutt E, Doyle AE, Nigg JT, et al. Validity of the executive function theory of attention deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry. 2005;57:1336–1346. [PubMed: 15950006]

  • Wilens TE, McDermott S, Biederman J, et al. Cognitive therapy for adults with ADHD: a systematic chart review of 26 cases. Journal of Cognitive Psychotherapy. 1999;13:215–226.

  • Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry. 2001;158:282–288. [PubMed: 11156812]

    This is the reference for WILENS2001A.

  • Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111:179–185. [PubMed: 12509574]

  • Wilens TE, Haight BR, Horrigan JP, et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomised, placebo-controlled study. Biological Psychiatry. 2005;57:793–801. [PubMed: 15820237]

  • Wilens T, McBurnett K, Stein M, et al. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open label study. Journal of the American Academy of Child and Adolescent Psychiatry. 2005;44:1015–1023. [PubMed: 16175106]

  • Wilens TE, McBurnett K, Bukstein O, et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Archives of Pediatrics and Adolescent Medicine. 2006;160:82–90. [PubMed: 16389216]

  • Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry. 2008;47:21–31. [PubMed: 18174822]

  • Wilkinson S. Focus groups in health research: exploring the meanings of health and illness. Journal of Health Psychology. 1998;3:329–348. [PubMed: 22021395]

  • Willcutt EG, Pennington BF, DeFries JC. Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder. American Journal of Medical Genetics. 2000;96:293–301. [PubMed: 10898903]

  • Willcutt EG, Pennington BF, Olsen RK, et al. Understanding comorbidity: a twin study of reading disability and attention-deficit/hyperactivity disorder. American Journal of Medical Genetics. 2007;144B:709–714. [PubMed: 17440942]

  • Williams JI, Cram DM, Tusig FT, et al. Relative effects of drugs and diet on hyperactive behaviors: an experimental study. Pediatrics. 1978;61:811–817. [PubMed: 353680]

  • Wilson JM, Marcotte AC. Psychosocial adjustment and educational outcome in adolescents with a childhood diagnosis of attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:579–587. [PubMed: 8935204]

  • Wolraich ML, Hannah JN, Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit-hyperactivity-disorder in a country-wide sample. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:319–324. [PubMed: 8714320]

  • Wolraich ML, Hannah JN, Baumgaertel A, et al. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. Journal of Developmental and Behavioral Pediatrics. 1998;19:162–168. [PubMed: 9648041]

  • Wolraich M, Lambert E, Baumgaertel A, et al. Teachers’ screening for attention deficit/hyperactivity disorder: comparing multinational samples on teacher ratings of ADHD. Journal of Abnormal Child Psychology. 2003;31:445–455. [PubMed: 12831232]

  • Wolraich ML, Lambert EW, Bickman L, et al. Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Developmental and Behavioural Pediatrics. 2004;25:41–47. [PubMed: 14767355]

  • Wolraich ML, McGuinn L, Doffing M. Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Safety. 2007;30:17–26. [PubMed: 17194168]

  • Woods SP, Lovejoy DW, Ball JD. Neuropsychological characteristics of adults with ADHD: a comprehensive review of initial studies. The Clinical Neuropsychologist. 2002;16:12–34. [PubMed: 11992223]

  • World Federation for Mental Health . Without Boundaries: Challenges and Hopes for Living With ADHD. An International Survey. 2005. Available at: http://www​.wfmh.org/

  • World Health Organization. The ICD–10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.

  • Wright P, Turner C, Clay D, et al. The Participation of Children and Young People in Developing Social Care. London: SCIE; 2006.

  • Young S. Psychological therapy for adults with Attention Deficit Hyperactivity Disorder. Counselling Psychology Quarterly. 1999;12:183–190.

  • Young S. A model of psychotherapy for adults with ADHD, Clinical Interventions for Adult ADHD: A Comprehensive Approach. Goldstein S, Teeter A, editors. Orlando, Florida: Harcourt; Academic Press; 2002. pp. 147–163.

  • Young S. Psychological therapy for adults with attention deficit hyperactivity disorder, Handbook of Attention Deficit Hyperactive Disorder. Fitzgerald M, Bellgrove M, Gill M, editors. Chichester: John Wiley; 2007.

  • Young S. Forensic aspects of ADHD, Handbook of Attention Deficit Hyperactive Disorder. Fitzgerald M, Bellgrove M, Gill M, editors. Chichester: John Wiley; 2007.

  • Young S, Bramham J. ADHD in Adults: a Psychological Guide to Practice. Chichester: John Wiley & Sons; 2007.

  • Young S, Toone B, Tyson C. Comorbidity and psychosocial profile of adults with attention deficit hyperactivity disorder. Personality and Individual Differences. 2003;35:743–755.

  • Young S, Heptinstall E, Sonuga-Barke EJS, et al. The adolescent outcome of hyperactive girls: self-report of psychosocial status. The Journal of Child Psychology and Psychiatry. 2005;46:255–262. [PubMed: 15755302]

  • Young S, Heptinstall E, Sonuga-Barke EJS, et al. The adolescent outcome of hyperactive girls: interpersonal relationships and coping mechanisms. European Child and Adolescent Psychiatry. 2005;14:245–253. [PubMed: 15981136]

  • Young S, Bramham J, Gray K, et al. The experience of receiving a diagnosis and treatment of ADHD in adulthood. A qualitative study of clinically referred patients using interpretative phenomenological analysis. Journal of Attention Disorders. 2008 [PubMed: 17712173]

  • Young S, Bramham J, Gray K. The experience of receiving a diagnosis and treatment of ADHD in adulthood from a partner’s perspective. A qualitative study of partners of clinically referred patients using interpretative phenomenological analysis. Journal of Attention Disorders. 2008 [PubMed: 17712173]

  • Zentall SS. Research on the educational implications of attention deficit hyperactivity disorder. Exceptional Children. 1993;60:143–153.

  • Zuddas A, Marzocchi GM, Oosterlaan J, et al. Factor structure and cultural factors of disruptive behavior disorders symptoms in Italian children. European Psychiatry. 2006;21:410–418. [PubMed: 16356689]

  • Zupancic JAF, Miller A, Raina P, et al. Economic evaluation of pharmaceutical and psychological/behavioural therapies for attention-deficit/hyperactivity disorder, A Review of Therapies for Attention Deficit/Hyperactivity Disorder. Miller A, Lee SK, Raina P, et al., editors. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1998. pp. 132–162.